Geriatric Depression Scale (GDS). Recent Evidence and Development ... Best Practices in Nursing Care to Older Adults," developed by the Hartford Institute for Geriatric Nursing.
Hosted on MSN1d
Supernus’s stock sinks after depression drug fails trialSupernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...
1d
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) revealed the topline data from the Phase 2b study of SPN-820 in adults with ...
Hosted on MSN1mon
Study sheds light on depression in community-dwelling older adultsOlder adults who had a negative history of depression ... The Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale was used to determine the depression status.
2d
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...
Supernus (SUPN) announced that the Phase 2b study of SPN-820 in adults with treatment-resistant depression did not demonstrate a statistically ...
Spravato is the first monotherapy for adults with major depressive disorder ... superior improvement in Montgomery-Asberg Depression Rating Scale (MADRS) total score compared with placebo.
"This large-scale study including data from 49 ... "Our sample included cognitively normal older adults without significant depression and with low levels of amyloid at baseline," she explained.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback